Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Abeona Therapeutics Inc has a consensus price target of $16 based on the ratings of 5 analysts. The high is $21 issued by Stifel on May 30, 2024. The low is $6 issued by SVB Leerink on November 14, 2022. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, HC Wainwright & Co., and HC Wainwright & Co. on September 20, 2024, August 14, 2024, and July 12, 2024, respectively. With an average price target of $16 between Cantor Fitzgerald, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 176.82% upside for Abeona Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Abeona Therapeutics (NASDAQ:ABEO) was reported by Cantor Fitzgerald on September 20, 2024. The analyst firm set a price target for $18.00 expecting ABEO to rise to within 12 months (a possible 211.42% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Abeona Therapeutics (NASDAQ:ABEO) was provided by Cantor Fitzgerald, and Abeona Therapeutics reiterated their overweight rating.
There is no last upgrade for Abeona Therapeutics
The last downgrade for Abeona Therapeutics Inc happened on November 30, 2021 when SVB Leerink changed their price target from $5 to $1 for Abeona Therapeutics Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Abeona Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Abeona Therapeutics was filed on September 20, 2024 so you should expect the next rating to be made available sometime around September 20, 2025.
While ratings are subjective and will change, the latest Abeona Therapeutics (ABEO) rating was a reiterated with a price target of $18.00 to $18.00. The current price Abeona Therapeutics (ABEO) is trading at is $5.78, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.